King D W, Reed E, Suciu-Foca N
Department of Pathology, University of Chicago, Ill.
Immunol Res. 1989;8(4):249-62. doi: 10.1007/BF02935510.
The MHC plays an essential role in regulating the process of self-nonself discrimination. T cells recognize nonself antigens only in the context of self-MHC gene products. It is not clear, however, whether B cells are also endowed with immune receptors for self-MHC antigens. We have explored the existence of antibodies against self-MHC antigens (HLA) in the human by analyzing the specificity of anti-HLA antibodies developed by a population of 727 dialysis patients who had been monitored monthly over a period of 3-78 months. Anti-HLA autoantibodies were identified by serum screening in 119 patients. Twenty-five of these 119 patients had not been exposed to alloantigens before, indicating that the production of anti-HLA autoantibodies is not necessarily stimulated by allogeneic HLA antigens. Cross-matching of sera with autologous lymphocytes, confirmed the autoreactive nature of these anti-HLA antibodies which were of IgM or of IgG isotype in approximately equal numbers of patients. The fine specificities of anti-HLA autoantibodies was ascertained in studies which showed that antibodies can be adsorbed, and the eluted, from the membranes of target cells carrying then relevant HLA antigen. Since the antibodies characterized in our studies may be functionally active in vivo we examined the possibility that their level is controlled by anti-idiotypic antibodies or by soluble HLA antigens. We found that the titer of anti-HLA autoantibodies increased significantly if soluble HLA antigens were depleted from the serum. Our data suggest that circulating HLA antigens form immune complexes with anti-HLA autoantibodies and contribute to the maintenance of self-tolerance by inhibiting antibody binding to membrane HLA antigens. The finding that the immune repertoire includes B cells with receptors for self-MHC opens new perspectives for the study of network perturbations in autoimmune diseases.
主要组织相容性复合体(MHC)在调节自身与非自身识别过程中起着至关重要的作用。T细胞仅在自身MHC基因产物的背景下识别非自身抗原。然而,B细胞是否也具有针对自身MHC抗原的免疫受体尚不清楚。我们通过分析727名透析患者群体产生的抗HLA抗体的特异性,探讨了人体内抗自身MHC抗原(HLA)抗体的存在情况。这些患者在3至78个月的时间里每月接受监测。通过血清筛查在119名患者中鉴定出抗HLA自身抗体。这119名患者中有25名此前未接触过同种异体抗原,这表明抗HLA自身抗体的产生不一定受到同种异体HLA抗原的刺激。血清与自体淋巴细胞的交叉配型证实了这些抗HLA抗体的自身反应性,在大约相同数量的患者中,这些抗体为IgM或IgG同种型。在研究中确定了抗HLA自身抗体的精细特异性,结果表明抗体可以从携带相关HLA抗原的靶细胞膜上吸附并洗脱下来。由于我们研究中所鉴定的抗体在体内可能具有功能活性,我们研究了其水平是否受抗独特型抗体或可溶性HLA抗原控制的可能性。我们发现,如果从血清中去除可溶性HLA抗原,抗HLA自身抗体的滴度会显著增加。我们的数据表明,循环中的HLA抗原与抗HLA自身抗体形成免疫复合物,并通过抑制抗体与膜HLA抗原的结合有助于维持自身耐受性。免疫库中存在具有自身MHC受体的B细胞这一发现为自身免疫性疾病中网络扰动的研究开辟了新的视角。